17-41226872-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_031961.3(KRTAP9-2):c.218C>A(p.Thr73Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,612,996 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_031961.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KRTAP9-2 | NM_031961.3 | c.218C>A | p.Thr73Asn | missense_variant | 1/1 | ENST00000377721.3 | NP_114167.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KRTAP9-2 | ENST00000377721.3 | c.218C>A | p.Thr73Asn | missense_variant | 1/1 | NM_031961.3 | ENSP00000366950 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 151874Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000440 AC: 11AN: 249930Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135380
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461002Hom.: 0 Cov.: 208 AF XY: 0.0000151 AC XY: 11AN XY: 726854
GnomAD4 genome AF: 0.000158 AC: 24AN: 151994Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74288
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 04, 2024 | The c.218C>A (p.T73N) alteration is located in exon 1 (coding exon 1) of the KRTAP9-2 gene. This alteration results from a C to A substitution at nucleotide position 218, causing the threonine (T) at amino acid position 73 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at